Active, not recruitingPhase 3NCT02813824

Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome

Studying Hereditary nonpolyposis colon cancer

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Robert BENAMOUZIG, Pr
Assistance Publique - Hôpitaux de Paris
Intervention
Acetylsalicylic acid lysinate 300 mg(drug)
Enrollment
852 enrolled
Eligibility
18-75 years · All sexes
Timeline
2017 – 2027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02813824 on ClinicalTrials.gov

Other trials for Hereditary nonpolyposis colon cancer

Additional recruiting or active studies for the same condition.

See all trials for Hereditary nonpolyposis colon cancer →

← Back to all trials